Rafferty Asset Management, LLC
Position in CATX — Perspective Therapeutics, Inc.
CIK 1389426
New York, NY
Position in CATX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$382,581
-$4,445 QoQ
Shares Held
112,194
+20.9% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 130 holders
Holding Since
Sep 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $91,709,703 across 11 Medical Devices names. CATX ranks #11 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GEHC |
GE HealthCare Technologies Inc.
|
272,193 | $17,423,073 | |
| 2 | ABT |
Abbott Laboratories
|
191,733 | $17,397,852 | |
| 3 | DXCM |
Dexcom Inc
|
230,257 | $15,507,808 | |
| 4 | SYK |
Stryker Corp
|
37,980 | $11,957,623 | |
| 5 | MDT |
Medtronic plc
|
141,328 | $11,056,089 | |
| 6 | BSX |
Boston Scientific Corp
|
163,616 | $6,983,130 | |
| 7 | EW |
Edwards Lifesciences Corp
|
63,382 | $5,733,535 | |
| 8 | STE |
STERIS plc
|
10,798 | $2,273,734 |
All Filings in CATX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $382,581 | 112,194 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $387,026 | 92,812 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $1,350,192 | 101,138 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||